Caribou Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Profitability This table compares iTeos Therapeutics and […]

Aura Biosciences (NASDAQ:AURA – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Institutional and Insider Ownership 96.8% of Aura […]

Investors didn't like the clinical-stage biotech's Q4 update for one key reason.

In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gaining the first FDA approval for a CRISPR-based drug, exagamglogene autotemcel (Casgevy) for the treatment of sickle cell disease with vaso-occlusive crisis.

Key Insights Institutions' substantial holdings in Caribou Biosciences implies that they have significant influence...